Table: begin end state 1 31 signal peptide 32 47 non-cytoplasmic 48 69 transmembrane 70 75 cytoplasmic 76 96 transmembrane 97 101 non-cytoplasmic 102 122 transmembrane 123 134 cytoplasmic 135 159 transmembrane 160 164 non-cytoplasmic 165 185 transmembrane 186 233 cytoplasmic 234 249 transmembrane 250 253 cytoplasmic 254 264 non-cytoplasmic 265 289 transmembrane 290 303 cytoplasmic 304 322 transmembrane 323 327 non-cytoplasmic 328 349 transmembrane 350 359 cytoplasmic 360 385 transmembrane 386 389 non-cytoplasmic 390 412 transmembrane 413 432 cytoplasmic
Input: >RR42_RS11305 MKHIKGMRWWMVSLVTMGLIVNYLARNTLSVAAPTMMSELHMTTQQYSYVVVAWQVCYAM MQPVAGLVLDAIGTKIGFGIFALAWSLACAAAALASGWQGLAFFRGLLGLAEAAGIPGGV KATTEWFPAKERSIAIGWFNIGSSIGALCAPPLVVWTILNGGWQRAFIIVGALGVAWTVL WMLCYKHPKNQQRLSDQEREYILAGQEAQHKDANMAKASWLEIMRSRNFWSIAIPRFLSE PAWQTFNAWIPLYMATERHMNIKEIAMFAWLPFLAADIGCVLGGYLSPWFHKHLKVSLFT SRKLVMLVGCLAMIGPACVGLVDSPYSAIALLCVGGFAHQTLSGALYSITSDAFGKNEVA TATGLAGMSGYLGATLFTLLFGIAVTHIGYSPLFVLLAVFDLIAAAIVFLMARERAAPGA AAANLGSPALHS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server